Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
Updated 2026-06-05
Laboratory Corporation of America Holdings (LH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $632.30M | $709.70M | $780.90M | $862.40M | $883.60M | $855.60M | $841.40M | $818.70M | $739.00M | $982.40M | $1.18B | $1.46B | $1.31B | $1.44B | $2.14B | $3.11B | $1.96B | $1.33B | $1.59B | $1.64B |
| Capital expenditures | $116.50M | $143.30M | $156.70M | $114.70M | $126.50M | $145.70M | $176.30M | $202.20M | $203.50M | $255.80M | $278.90M | $315.40M | $379.80M | $400.20M | $381.70M | $460.40M | $481.90M | $453.60M | $489.90M | $434.50M |
| Depreciation | $155.00M | $162.80M | $179.70M | $195.10M | $203.60M | $231.40M | $229.80M | $230.10M | $245.50M | $457.80M | $499.20M | $533.20M | $552.10M | $577.20M | $624.70M | $745.10M | $633.90M | $577.30M | $643.50M | $681.10M |
| Stock-based comp | $52.70M | $-8.40M | $36.20M | $36.40M | $40.00M | $48.90M | $40.70M | $37.30M | $45.70M | $102.10M | $109.60M | $109.70M | $91.60M | $107.00M | $111.70M | $153.70M | $144.10M | $128.70M | $116.70M | $125.80M |
| Free cash flow | $515.80M | $566.40M | $624.20M | $747.70M | $757.10M | $709.90M | $665.10M | $616.50M | $535.50M | $726.60M | $897.00M | $1.14B | $925.60M | $1.04B | $1.75B | $2.65B | $1.47B | $874.10M | $1.10B | $1.21B |
| Investing cash flow | $-273.30M | $-341.50M | $-396.00M | $-334.00M | $-1.32B | $-280.30M | $-534.20M | $-359.60M | $-350.10M | $-3.99B | $-795.70M | $-2.23B | $206.70M | $-1.28B | $-643.20M | $-884.60M | $-1.65B | $-1.17B | $-1.37B | $-1.19B |
| Financing cash flow | $-353.50M | $-363.70M | $-218.50M | $-600.90M | $515.30M | $-645.00M | $-800000.00 | $-518.30M | $-200.60M | $3.18B | $-649.80M | $631.90M | $-1.39B | $-252.70M | $-517.40M | $-2.07B | $-1.32B | $-59.30M | $779.90M | $-1.46B |
| Dividends paid | — | — | $370.90M | $592.70M | $551.20M | $1.38B | $1.30B | $1.11B | $1.20M | $0.00 | $139.50M | $3.34B | $467.20M | $2.40B | $151.70M | $1.00B | $195.20M | $254.00M | $243.10M | $240.70M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-71.20M | $82.20M | $-71.40M | $307.50M | $-62.80M | $176.00M | $136.40M | $-282.80M | $-116.90M | $110.20M | — | — | — | — | — | — | — |
Frequently asked questions
What is Laboratory Corporation of America Holdings's revenue?
Laboratory Corporation of America Holdings's trailing twelve-month revenue is $14.14B, and consensus projects about $17.77B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is LH?
In its most recent fiscal year, LH ran a gross margin of 26.75%, an operating margin of 10.87%, and a net margin of 6.28%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does LH generate?
LH produced $1.21B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is LH's balance sheet healthy?
LH holds $532.30M in cash and equivalents against $5.08B in long-term debt, on $8.62B of shareholder equity. That debt is best read against the cash flow the business throws off each year.